Volume 73, Issue 5 , Pages 1293-1303, 1 April 2009
Larynx Preservation Clinical Trial Design: Key Issues and Recommendations—A Consensus Panel Summary
To access this article, please choose from the options below
Sources of support: Sanofi-Aventis.
Conflict of interest: Jean-Louis Lefebvre has potential conflicts of interest with Sanofi-Aventis, Merck Serono, IRX Therapeutics, and Genmab. K. Kian Ang has served on Advisory Boards of AstraZeneca, BMS, Imclone Systems Inc., Merck Serono, and Sanofi-Aventis. These commitments do not interfere with performing the task presented in the manuscript.
To be published simultaneously in Head & Neck.
PII: S0360-3016(08)03693-6
doi:10.1016/j.ijrobp.2008.10.047
© 2009 Elsevier Inc. and Wiley-Blackwell Inc. Published by Elsevier Inc All rights reserved.
Volume 73, Issue 5 , Pages 1293-1303, 1 April 2009
